INPP5D expression and SHIP1 activity have been shown to be important risk factors in the development of late-onset AD, as the various mechanistic actions of SHIP1 in microglia result in dampening of signaling, and consequently of some of the beneficial functions of these cells. The gene discussed is INPP5D; the disease is Alzheimer disease.